Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01012414 · ClinicalTrials.gov registry record · Phase 3
Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
A Phase 3 study, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT01012414 is a Phase 3 study that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 10 participants.
The verdict
NCT01012414, a Phase 3 study, was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if vitamin D supplementation changes the results of certain tests associated with inflammation in the body using an oral, synthetic form of vitamin D called paricalcitol.
Interventions
- DRUG placebo
- DRUG paricalcitol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01012414
The ClinicalTrials.gov registry entry for NCT01012414 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01012414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01012414 about?
NCT01012414 is a clinical study titled "Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease". The purpose of this study is to determine if vitamin D supplementation changes the results of certain tests associated with inflammation in the body using an oral, synthetic form of vitamin D called paricalcitol.
What is the current status of trial NCT01012414?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2010-01. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01012414?
The interventions under investigation include: placebo (DRUG), paricalcitol (DRUG).
Who is sponsoring clinical trial NCT01012414?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.